Back to Search Start Over

Novo Holdings backs Sangon Biotech in $290M financing round.

Authors :
Masson, Gabrielle
Source :
FierceBiotech; 8/17/2023, pN.PAG-N.PAG, 1p
Publication Year :
2023

Abstract

Novo Holdings is backing Sangon Biotech in a $290 million financing round that will help the China-based company grow internationally. [ABSTRACT FROM AUTHOR]

Subjects

Subjects :
CONTRACT research organizations

Details

Language :
English
Database :
Complementary Index
Journal :
FierceBiotech
Publication Type :
Periodical
Accession number :
170047553

Tools

Authors Abstract Subjects Details